An official website of the United States government
TABLE 9. Estimated percent using an inhaled corticosteroid in the past 3 months among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey Land Line Sample, United States, 2012
| State/Territory | Current | Active | ||||||
|---|---|---|---|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | |
| Alabama | 268 | 42.5 | 6.2 | (30.3 – 54.7) | 271 | 42.7 | 6.3 | (30.4 – 55.0) |
| Arizona | 222 | 34.4 | 6.6 | (21.5 – 47.3) | 229 | 25.4 | 6.7 | (12.3 – 38.5) |
| California | 316 | 39.0 | 4.5 | (30.2 – 47.8) | 336 | 36.9 | 4.3 | (28.5 – 45.3) |
| Connecticut | 241 | 43.3 | 5.6 | (32.3 – 54.3) | 249 | 42.3 | 5.9 | (30.7 – 53.9) |
| District of Columbia | 98 | 32.7 | 8.8 | (15.5 – 49.9) | 106 | 37.9 | 10.4 | (17.5 – 58.3) |
| Florida | 215 | 41.4 | 8.5 | (24.7 – 58.1) | 230 | 43.1 | 8.2 | (27.0 – 59.2) |
| Georgia | 142 | 32.0 | 7.2 | (17.9 – 46.1) | 160 | 29.7 | 6.6 | (16.8 – 42.6) |
| Hawaii | 143 | 29.7 | 6.6 | (16.8 – 42.6) | 152 | 38.6 | 6.3 | (26.3 – 50.9) |
| Illinois | 205 | 32.0 | 5.3 | (21.6 – 42.4) | 219 | 28.4 | 5.0 | (18.6 – 38.2) |
| Indiana | 238 | 28.5 | 4.5 | (19.7 – 37.3) | 260 | 25.1 | 4.1 | (17.1 – 33.1) |
| Iowa | 197 | 24.4 | 4.3 | (16.0 – 32.8) | 201 | 25.0 | 4.3 | (16.6 – 33.4) |
| Kansas | 388 | 34.3 | 4.4 | (25.7 – 42.9) | 402 | 34.7 | 4.3 | (26.3 – 43.1) |
| Louisiana | 261 | 30.2 | 5.8 | (18.8 – 41.6) | 274 | 26.3 | 5.3 | (15.9 – 36.7) |
| Maine | 216 | 45.3 | 5.8 | (33.9 – 56.7) | 228 | 44.7 | 5.5 | (33.9 – 55.5) |
| Massachusetts | 198 | 34.5 | 5.7 | (23.3 – 45.7) | 232 | 31.1 | 5.0 | (21.3 – 40.9) |
| Michigan | 448 | 35.8 | 3.7 | (28.5 – 43.1) | 488 | 34.7 | 3.6 | (27.6 – 41.8) |
| Mississippi | 261 | 20.7 | 3.5 | (13.8 – 27.6) | 261 | 20.9 | 3.5 | (14.0 – 27.8) |
| Missouri | 227 | 37.0 | 6.1 | (25.0 – 49.0) | 240 | 33.5 | 5.8 | (22.1 – 44.9) |
| Montana | 277 | 39.6 | 6.0 | (27.8 – 51.4) | 289 | 37.9 | 6.0 | (26.1 – 49.7) |
| Nebraska | 508 | 35.0 | 4.0 | (27.2 – 42.8) | 523 | 34.2 | 3.9 | (26.6 – 41.8) |
| Nevada | 142 | 20.7 | 4.9 | (11.1 – 30.3) | 158 | 19.0 | 4.4 | (10.4 – 27.6) |
| New Hampshire | 264 | 29.3 | 3.9 | (21.7 – 36.9) | 281 | 29.5 | 3.7 | (22.2 – 36.8) |
| New Jersey | 385 | 25.6 | 3.8 | (18.2 – 33.0) | 409 | 25.5 | 3.6 | (18.4 – 32.6) |
| New Mexico | 292 | 44.3 | 5.0 | (34.5 – 54.1) | 307 | 41.8 | 4.8 | (32.4 – 51.2) |
| New York | 173 | 29.2 | 5.9 | (17.6 – 40.8) | 189 | 30.2 | 5.8 | (18.8 – 41.6) |
| North Carolina | 155 | 37.8 | 8.2 | (21.7 – 53.9) | 174 | 32.8 | 7.5 | (18.1 – 47.5) |
| North Dakota | 150 | 30.1 | 5.3 | (19.7 – 40.5) | 149 | 28.6 | 5.2 | (18.4 – 38.8) |
| Ohio | 393 | 30.2 | 3.9 | (22.6 – 37.8) | 416 | 27.2 | 3.8 | (19.8 – 34.6) |
| Oklahoma | 210 | 33.8 | 6.8 | (20.5 – 47.1) | 216 | 29.2 | 6.5 | (16.5 – 41.9) |
| Oregon | 198 | 26.9 | 4.3 | (18.5 – 35.3) | 220 | 25.3 | 3.9 | (17.7 – 32.9) |
| Pennsylvania | 577 | 38.7 | 4.4 | (30.1 – 47.3) | 617 | 37.0 | 4.2 | (28.8 – 45.2) |
| Rhode Island | 187 | 45.9 | 6.3 | (33.6 – 58.2) | 190 | 42.1 | 6.2 | (29.9 – 54.3) |
| Texas | 212 | 36.8 | 8.5 | (20.1 – 53.5) | 220 | 32.9 | 8.1 | (17.0 – 48.8) |
| Vermont | 234 | 33.0 | 4.6 | (24.0 – 42.0) | 244 | 31.4 | 4.3 | (23.0 – 39.8) |
| Washington | 463 | 39.6 | 4.3 | (31.2 – 48.0) | 487 | 39.2 | 4.0 | (31.4 – 47.0) |
| West Virginia | 211 | 30.2 | 3.9 | (22.6 – 37.8) | 212 | 31.1 | 3.9 | (23.5 – 38.7) |
| Wisconsin | 181 | 46.4 | 8.2 | (30.3 – 62.5) | 185 | 47.3 | 8.2 | (31.2 – 63.4) |
| 37 state total | 9,496 | 35.2 | 1.4 | (32.5 – 37.9) | 10,024 | 33.2 | 1.4 | (30.5 – 35.9) |
| Median | 34.3 | 32.8 | ||||||
| Range | 20.7-46.4 | 19.0-47.3 | ||||||
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Landline sample size excludes “DK/Refused”
§ Standard error
† Confidence interval